Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(1)

DRUG(1)

Oral roflumilast

1 trial

phase_2

the-university-of-hong-kong

Osimertinib plus platinum doublet chemotherapy

1 trial

phase_2

the-university-of-hong-kong

2 unique interventions2 categories

Analytics

Trial Phases

Phase 22

Trial Status

Completed1

Other1

Role Distribution

Principal Investigator2

PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03428334Phase 2Completed

Roflumilast in Non-CF Bronchiectasis Study

Non-cystic Fibrosis Bronchiectasis

PrincipalinvestigatorStart date: 2018-05-10

NCT06918782Phase 2Not Yet Recruiting

Real-world Experience With Combination Chemotherapy and Osimertinib in Poor Prognostic Group of Metastatic EGFR-mutated Lung Adenocarcinoma

Lung Cancer (NSCLC)

Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Lung Cancer (NSCLC)1 Non-cystic Fibrosis Bronchiectasis1

Affiliations

The University of Hong Kong

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Marion FERREIRA, Dr

University Hospital, Tours

2 trials

Shared therapeutic areas:

Lung Cancer (NSCLC)

Similarity Score15%

Ahmad M. shaddad, MD

Assiut University

6 trials

Shared therapeutic areas:

Non-cystic Fibrosis Bronchiectasis

Similarity Score15%

Ahmad M Shaddad, MD

Assiut University

3 trials

Shared therapeutic areas:

Non-cystic Fibrosis Bronchiectasis

Similarity Score15%

Alaa S. Ali

Assiut University

1 trials

Shared therapeutic areas:

Non-cystic Fibrosis Bronchiectasis

Similarity Score15%

Bryan Taylor, PhD

Mayo Clinic

3 trials

Shared therapeutic areas:

Non-cystic Fibrosis Bronchiectasis

Similarity Score15%

Shugeng Gao, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

4 trials

Shared therapeutic areas:

Lung Cancer (NSCLC)

Similarity Score15%

Aliae A. Hussien, MD

Assiut University

8 trials

Shared therapeutic areas:

Non-cystic Fibrosis Bronchiectasis

Similarity Score15%

Maiada K. Hashem, MD

Assiut University

5 trials

Shared therapeutic areas:

Non-cystic Fibrosis Bronchiectasis

Similarity Score15%

Jiayuan Sun, MD, PhD

Shanghai Chest Hospital

13 trials

Shared therapeutic areas:

Lung Cancer (NSCLC)

Similarity Score15%

Alaa Sayed, MD

Assiut University

1 trials

Shared therapeutic areas:

Non-cystic Fibrosis Bronchiectasis

Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03428334Phase 2PrincipalInvestigator

Roflumilast in Non-CF Bronchiectasis Study

Non-cystic Fibrosis Bronchiectasis

Completed

NCT06918782Phase 2PrincipalInvestigator

Real-world Experience With Combination Chemotherapy and Osimertinib in Poor Prognostic Group of Metastatic EGFR-mutated Lung Adenocarcinoma

Lung Cancer (NSCLC)

Not Yet Recruiting

All 2 trials loaded